<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02645773</url>
  </required_header>
  <id_info>
    <org_study_id>Early intevention</org_study_id>
    <nct_id>NCT02645773</nct_id>
  </id_info>
  <brief_title>Early Intervention With Non-ablative Fractional Laser to Reduce Cutaneous Scarring</brief_title>
  <official_title>Early Intervention With Non-ablative Fractional Laser to Reduce Cutaneous Scarring</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Bispebjerg Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Bispebjerg Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      To investigate intervention with early application of non-ablative laser to prevent scarring
      in the skin
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      To intervene in scar formation at three different time-points
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>September 2015</start_date>
  <completion_date type="Actual">January 2016</completion_date>
  <primary_completion_date type="Actual">December 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>To measure the clinical effect on scarring of non-ablative laser intervention at the three time-points</measure>
    <time_frame>3 months after</time_frame>
    <description>Clinical evaluation by scar scales</description>
  </primary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Actual">16</enrollment>
  <condition>Cicatrix</condition>
  <arm_group>
    <arm_group_label>Pre-laser</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>non-ablative laser Laser Pre-wounding low dose laser Pre-wounding medium dose laser Pre-wounding high dose</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Immediate-laser</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>non-ablative laser Laser low dose - immediate after wounding Laser medium dose - immediate after wounding Laser high dose - immediate after wounding</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Post-laser</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>non-ablative laser Laser low dose - post wounding Laser medium dose - post wounding Laser medium dose - post wounding</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Untreated control wound</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>non-ablative laser</intervention_name>
    <description>non-abaltive laser pre, immediate and post wounding</description>
    <arm_group_label>Pre-laser</arm_group_label>
    <arm_group_label>Immediate-laser</arm_group_label>
    <arm_group_label>Post-laser</arm_group_label>
    <other_name>Erbium:glass laser</other_name>
    <other_name>1540 nm laser</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  good health

          -  men

          -  Skin type 2-3

          -  non-smokers

          -  presenting full medical record

        Exclusion Criteria:

          -  active skin disease in test area

          -  resent UV-exposure in test area

          -  history of keloid

          -  current or resent cancer

          -  uncontrolled systemical disease
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Merete Haedersdal, professor</last_name>
    <role>Principal Investigator</role>
    <affiliation>Bispebjerg Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Bispebjerg Hospital</name>
      <address>
        <city>Copenhagen</city>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <verification_date>February 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 30, 2015</study_first_submitted>
  <study_first_submitted_qc>December 31, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 5, 2016</study_first_posted>
  <last_update_submitted>February 8, 2016</last_update_submitted>
  <last_update_submitted_qc>February 8, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 9, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Bispebjerg Hospital</investigator_affiliation>
    <investigator_full_name>Katrine Elisabeth Karmisholt</investigator_full_name>
    <investigator_title>MD</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cicatrix</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

